HCW Biologics Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
HCW Biologics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2024.
- HCW Biologics Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$3.9M, a 21% increase year-over-year.
- HCW Biologics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$37.3M, a 89.2% decline year-over-year.
- HCW Biologics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$25M, a 67.7% decline from 2022.
- HCW Biologics Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$14.9M, a 15.8% decline from 2021.
- HCW Biologics Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$12.9M, a 122% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)